Beyond Function: Eydology Redefines Professional Identity with High-Style, Affordable Prescription Glasses for the Hybrid Work Era
As Wall Street Celebrates “Marijuana Rescheduling,” the Real Story Is Emerging: The DEA’s Own Final Rules Collide With the Political Hype
Action Behavior Centers Marks Autism Acceptance Month with Nationwide Celebrations and a Renewed Commitment to Inclusion
Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010
Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
bioLytical’s iStatis test delivers results in 15 minutes in clinical and community settings iStatis Hepatitis B Surface Antigen Test iStatis...
Agreement with St. Vincent Health marks HeartSciences’ transition from early adopter installations to commercial SaaS deployments following the full launch...
Colorado to become first state to license MAPS’ first-of-its-kind training for first responders.MAPS is partnering with the Colorado Department of...
OAKLAND, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Biosphere, a U.S.-based pioneer in biomanufacturing technology, today announced the award of...
CINCINNATI, May 05, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the...
Dr. Travis Schamber Promoted to Chief Medical Officer; Jennifer Haas Named Chief Marketing Officer; Shay Hurst Named Chief People OfficerATLANTA,...
Order supports customer’s full launch, with shipments expected to commence shortly and be fulfilled over 12 -15 monthsLITTLETON, Mass., May...
Ribbon Cutting Ceremony to Mark Continued Growth and Investment in U.S. OperationsROSWELL, Ga., May 05, 2026 (GLOBE NEWSWIRE) -- Cellution...
Vancouver, Canada, May 05, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech...
SALT LAKE CITY, May 05, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene” or the...
Conference Call and Webcast Today at 8:30 a.m. ET Positive 12-month data from the OCU410 Phase 2 ArMaDa clinical trial...
SARASOTA, Fla., May 05, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics...
FORT LAUDERDALE, Fla., May 05, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII),...
SEATTLE and VANCOUVER, British Columbia, May 05, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty...
First quarter revenue of $24.4M, +46% year-over-year growth; IFRS gross margin of 75.0%First quarter usage fee revenue of $11.0M, +56%...
Company focusing resources on near-term commercial milestones; European CE Mark process and Healthcare Research revenue opportunities Process intended to evaluate...
Data demonstrate colon tissue PDE4/cAMP pathway modulation and sustained active metabolite exposure above IC90 across the dosing interval Steady-state pharmacokinetic...
PARSIPPANY, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial...
Completed enrollment of the Phase 3 APOLLO study of bitopertin in erythropoietic protoporphyria (EPP); topline data expected in Q4 2026Updated...
LAWRENCEVILLE, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its...
